Sg3 Management, LLC Omeros Corp Call Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $105,456 - $149,760	-20,800 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$5.67 - $8.54 $340,200 - $512,399	-60,000 Reduced 74.26%	20,800 $134,000
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $694,120 - $844,340	51,800 Added 178.62%	80,800 $1.11 Million
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $133,290 - $172,170	9,000 Added 45.0%	29,000 $430,000
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $854,802 - $1.28 Million	-84,300 Reduced 80.82%	20,000 $286,000
Q3 2020 Nov 13, 2020	BUY	$9.57 - $21.32 $998,151 - $2.22 Million	104,300 New	104,300 $1.05 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $712M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.